Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ARTV is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 7 days ago
Red flags: 8
72 filers reported a long position in ARTV for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $174.2M | 18M | +82.2% |
| VIKING GLOBAL INVESTORS LP | $25.3M | 2.6M | New |
| Blackstone Inc. | $23.3M | 2.4M | New |
| 5AM Venture Management, LLC | $22.8M | 2.4M | Unchanged |
| Venrock Adviser, LLC | $19.8M | 2M | +27% |
| FRANKLIN RESOURCES INC | $19.4M | 2M | +283.8% |
| Caligan Partners LP | $16.8M | 1.7M | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.5M | 981.8K | +372.7% |
| Samsara BioCapital, LLC | $9.3M | 954.9K | New |
| Blue Owl Capital Holdings LP | $8.5M | 874.5K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.